4.5 Article

Does Contractile Ca2+ Control Calcineurin-NFAT Signaling and Pathological Hypertrophy in Cardiac Myocytes?

Journal

SCIENCE SIGNALING
Volume 1, Issue 25, Pages -

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/scisignal.125pe31

Keywords

-

Funding

  1. Howard Hughes Medical Institute Funding Source: Medline
  2. NHLBI NIH HHS [P01 HL069779, P01 HL069779-06A10003, R01 HL089312-03, R01 HL060562, R01 HL081104, R01 HL081104-04, R01 HL089312, P50 HL077101, R01 HL060562-11, R01 HL033921, R01 HL062927, R37 HL033921, R01 HL062927-10A1, P50 HL077101-050004] Funding Source: Medline

Ask authors/readers for more resources

In noncontractile cells, a sustained increase in total cytoplasmic Ca2+ concentration is typically needed to activate the intracellular protein phosphatase calcineurin, leading to dephosphorylation of the transcription factor nuclear factor of activated T cells (NFAT), its nuclear translocation, and induction of gene expression. It remains a mystery exactly how Ca2+-dependent signaling pathways, such as that mediated by calcineurin-NFAT, are regulated in contracting cardiac myocytes given the highly specialized manner in which Ca2+ concentration rhythmically cycles in excitation-contraction coupling. Here, we critically review evidence that supports the hypothesis that calcineurin-NFAT signaling is regulated by contractile Ca2+ transients in cardiac myocytes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available